Research Article

Treatment of Huge Hepatocellular Carcinoma Using Cinobufacini Injection in Transarterial Chemoembolization: A Retrospective Study

Table 2

Comparison of clinical efficacy of TACE between the groups.

GroupNumber of patients (%)
PRSDPDORDC

Cinobufacini group ()15 (48.4)10 (32.3)6 (19.4)15 (48.4)25 (80.6)
Epirubicin group ()5 (20.0)11 (44.0)9 (36.0)5 (20.0)16 (64.0)

, comparing with the epirubicin group.
PR: partial response; SD: stable disease; PD: progressive disease; OR: objective response; DC: disease control.